Scientists have solved the structure of an important complex of RAS-pathway proteins, explaining how known mutations lead to disease and suggesting potential new binding sites for cancer drugs.
By introducing cancer-causing mutations into healthy skin cells step-by-step, ӳý scientists have created models of skin cancer that can reveal the effects of mutations.